Biotech · Private company
Green Cross Corporation
Track this companyFree. Adds Green Cross Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- GC5107Phase 3 · Immunologic Deficiency SyndromesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult SubjectsPHASE1 · COMPLETED · started Jan 3, 2019ClinicalTrials.gov NCT03820414 · fetched Nov 12, 2026
- Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral ImmunodeficiencyPHASE3 · COMPLETED · started Oct 1, 2016ClinicalTrials.gov NCT02783482 · fetched Nov 12, 2026
- Safety Study of MGAH22 in HER2-positive CarcinomasPHASE1 · COMPLETED · started Jul 1, 2010ClinicalTrials.gov NCT01148849 · fetched Nov 12, 2026